The benchmark S&P 500 posted a 7% gain for the first quarter, which ended on Friday, rebounding after a nearly 20% drop in 2022. The Nasdaq Composite’s 16.8% first-quarter jump was its biggest quarterly rise since 2020.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This